Wąsik R - Search Results

1

100 years of therapy with insulin in Lower Silesia, Poland.

Wąsik R, Basiak A, Barg E. Wąsik R, et al. Pediatr Endocrinol Diabetes Metab. 2022;28(2):105-107. doi: 10.5114/pedm.2022.117417. Pediatr Endocrinol Diabetes Metab. 2022. PMID: 35848471 Free PMC article. No abstract available.

2

Specific IgE against milk allergens in children with insulin dependent diabetes mellitus.

Boznański A, Pirogowicz I, Wasik R, Barg E, Hebrowska A. Boznański A, et al. Among authors: wasik r. Rocz Akad Med Bialymst. 1995;40(3):494-8. Rocz Akad Med Bialymst. 1995. PMID: 8775296

3

A programme of iodine supplementation using only iodised household salt is efficient--the case of Poland.

Szybinski Z, Delange F, Lewinski A, Podoba J, Rybakowa M, Wasik R, Szewczyk L, Huszno B, Gołkowski F, Przybylik-Mazurek E, Karbownik M, Zak T, Pantoflinski J, Trofimiuk M, Kinalska I. Szybinski Z, et al. Among authors: wasik r. Eur J Endocrinol. 2001 Apr;144(4):331-7. doi: 10.1530/eje.0.1440331. Eur J Endocrinol. 2001. PMID: 11275941

4

Effectiveness of the iodine prophylaxis model adopted in Poland.

Szybinski Z, Golkowski F, Buziak-Bereza M, Trofimiuk M, Przybylik-Mazurek E, Huszno B, Bandurska-Stankiewicz E, Bar-Andziak E, Dorant B, Kinalska I, Lewinski A, Klencki M, Rybakowa M, Sowinski J, Szewczyk L, Szponar L, Wasik R. Szybinski Z, et al. Among authors: wasik r. J Endocrinol Invest. 2008 Apr;31(4):309-13. doi: 10.1007/BF03346363. J Endocrinol Invest. 2008. PMID: 18475048

5

Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.

Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, Walczak M, Wasik R, Ginalska-Malinowska M, Solyom E, Berghout A. Romer T, et al. Among authors: wasik r. J Endocrinol Invest. 2007 Jul-Aug;30(7):578-89. doi: 10.1007/BF03346352. J Endocrinol Invest. 2007. PMID: 17848841 Clinical Trial.

6

Genotype and soil substrate effects on the wood quality of poplar grown in a reclaimed lignite-mining area.

Pająk M, Vítek P, Urban O, Klem K, Wąsik R, Michalec K, Pietrzykowski M. Pająk M, et al. Among authors: wasik r. J Environ Manage. 2021 May 1;285:112146. doi: 10.1016/j.jenvman.2021.112146. Epub 2021 Feb 15. J Environ Manage. 2021. PMID: 33601261

7

Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.

Wąsik R, Wińska P, Poznański J, Shugar D. Wąsik R, et al. PLoS One. 2012;7(11):e48898. doi: 10.1371/journal.pone.0048898. Epub 2012 Nov 14. PLoS One. 2012. PMID: 23155426 Free PMC article.

8

Synthesis and physico-chemical properties in aqueous medium of all possible isomeric bromo analogues of benzo-1H-triazole, potential inhibitors of protein kinases.

Wąsik R, Wińska P, Poznański J, Shugar D. Wąsik R, et al. J Phys Chem B. 2012 Jun 21;116(24):7259-68. doi: 10.1021/jp301561x. Epub 2012 Jun 11. J Phys Chem B. 2012. PMID: 22632480 Free article.

9

Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland.

Szybiński Z; Polish Council for Control of Iodine Deficiency Disorders. Szybiński Z, et al. Endokrynol Pol. 2012;63(2):156-60. Endokrynol Pol. 2012. PMID: 22538756

10

Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2α by tetrabromobenzotriazole and some C5-substituted analogues.

Wasik R, Łebska M, Felczak K, Poznański J, Shugar D. Wasik R, et al. J Phys Chem B. 2010 Aug 19;114(32):10601-11. doi: 10.1021/jp102848y. J Phys Chem B. 2010. PMID: 20734498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page